Latest News in the pharma Industry

Research & Development

Bristol Myers Squibb disappointed with failed late-stage combo drug trial

Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial

9 Mar 2020

Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint.

Read more 
Nanoform and Orion collaborate on 'nanoformed' APIs

Nanoform and Orion collaborate on 'nanoformed' APIs

9 Mar 2020

Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges.

Read more 
Thermo Fisher Scientific to acquire Qiagen

Thermo Fisher Scientific to acquire Qiagen

3 Mar 2020

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

Read more 
Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven

3 Mar 2020

Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion.

Read more 
MindMed becomes world's first psychedelic pharma company to go public

MindMed becomes world's first psychedelic pharma company to go public

3 Mar 2020

The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Read more 
Potential first-in-class treatment reaches significant milestone

Potential first-in-class treatment reaches significant milestone

2 Mar 2020

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

Read more 
Merck KGaA,  AMCM/EOS co-operate in 3D printing of tablets

Merck KGaA, AMCM/EOS co-operate in 3D printing of tablets

27 Feb 2020

A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...

Read more 
BIA Separations signs agreement to commercialise novel elution technology

BIA Separations signs agreement to commercialise novel elution technology

26 Feb 2020

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.

Read more 
Non-hormonal treatment for menopausal hot flashes begins clinical trials

Non-hormonal treatment for menopausal hot flashes begins clinical trials

25 Feb 2020

The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.

Read more 
Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD

21 Feb 2020

Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase.

Read more 
New Velesco Pharma clinical manufacturing facility begins operations

New Velesco Pharma clinical manufacturing facility begins operations

5 Feb 2020

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

Read more 
Inovio and Beijing Advaccine to advance vaccine against Coronavirus

Inovio and Beijing Advaccine to advance vaccine against Coronavirus

30 Jan 2020

Agreement will facilitate clinical trial translations in China.

Read more